Canada

Canada

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value Year Type Source
1.85 2000 Modelled IHME
1.79 2010 Modelled IHME
1.79 2011 Modelled IHME
1.78 2012 Modelled IHME
1.77 2013 Modelled IHME
1.76 2014 Modelled IHME
1.75 2015 Modelled IHME
1.74 2016 Modelled IHME
1.73 2017 Modelled IHME
1.72 2018 Modelled IHME
1.71 2019 Modelled IHME
Showing out of
Show more
Children under-5 years
Download
Value Year Type Source
0.75 2000 Modelled IHME
0.47 2010 Modelled IHME
0.43 2011 Modelled IHME
0.4 2012 Modelled IHME
0.37 2013 Modelled IHME
0.35 2014 Modelled IHME
0.33 2015 Modelled IHME
0.31 2016 Modelled IHME
0.3 2017 Modelled IHME
0.28 2018 Modelled IHME
0.27 2019 Modelled IHME
Showing out of
Show more

Liver cancer deaths attributable to HBV

National
Download
Value Year Type Source
7.53 (5.16 - 10.88) 2000 Modelled IHME
6.74 (4.56 - 9.86) 2010 Modelled IHME
6.72 (4.53 - 9.85) 2011 Modelled IHME
6.77 (4.57 - 9.92) 2012 Modelled IHME
6.84 (4.60 - 10.06) 2013 Modelled IHME
6.9 (4.67 - 10.22) 2014 Modelled IHME
6.92 (4.66 - 10.29) 2015 Modelled IHME
6.83 (4.61 - 10.16) 2016 Modelled IHME
6.71 (4.46 - 9.94) 2017 Modelled IHME
6.57 (4.35 - 9.78) 2018 Modelled IHME
6.42 (4.29 - 9.52) 2019 Modelled IHME
Showing out of
Show more

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value Year Type Source
71 2018 Survey/reported WHO/UNICEF
71 2017 Survey/reported WHO/UNICEF
70 2016 Survey/reported WHO/UNICEF
69 2015 Survey/reported WHO/UNICEF
55 2014 Survey/reported WHO/UNICEF
55 2013 Survey/reported WHO/UNICEF
70 2012 Survey/reported WHO/UNICEF
70 2011 Survey/reported WHO/UNICEF
56 2010 Survey/reported WHO/UNICEF
42 2009 Survey/reported WHO/UNICEF
28 2008 Survey/reported WHO/UNICEF
14 2007 Survey/reported WHO/UNICEF
14 2006 Survey/reported WHO/UNICEF
14 2005 Survey/reported WHO/UNICEF
14 2004 Survey/reported WHO/UNICEF
14 2003 Survey/reported WHO/UNICEF
Showing out of
Show more

Number of needles/syringes per PWID per year

PWID
Download
Value Year Type Source
148 2015 Survey/reported Larney S et al, 2017
Eligible for HBV generic medications

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
0.8 2000 Modelled IHME
0.9 2010 Modelled IHME
0.9 2011 Modelled IHME
0.9 2012 Modelled IHME
0.9 2013 Modelled IHME
0.9 2014 Modelled IHME
0.9 2015 Modelled IHME
0.92 2016 Modelled IHME
0.94 2017 Modelled IHME
0.94 2018 Modelled IHME
0.93 2019 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

PWID
Download
Value Year Type Source
70.6 2014 Modelled Degenhardt L et al, 2017

Liver cancer deaths attributable to HCV

National
Download
Value Year Type Source
19.92 2000 Modelled IHME
20.17 2010 Modelled IHME
20.33 2011 Modelled IHME
20.36 2012 Modelled IHME
20.44 2013 Modelled IHME
20.39 2014 Modelled IHME
20.38 2015 Modelled IHME
19.96 2016 Modelled IHME
19.52 2017 Modelled IHME
19.42 2018 Modelled IHME
19.56 2019 Modelled IHME
Showing out of
Show more

Number of needles/syringes per PWID per year

PWID
Download
Value Year Type Source
148 2015 Survey/reported Larney S et al, 2017
Eligible for HBV generic medications

Overview

Prevalence (national)

Modelled

No data available
No data available

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

No data available
No data available
HBV chart
No data available
No data available
HCV chart

Prevalence < 5

No data available
No data available

Prevalence PWID

No data available
No data available

Birth dose vaccination coverage (national)

No data available

No. of syringes/PWID/year

No data available
Eligible for HBV generic medications
Eligible for HBV generic medications